Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) FCF Margin (2020 - 2025)

Historic FCF Margin for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 1151.73%.

  • Caribou Biosciences' FCF Margin rose 4952100.0% to 1151.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 1374.53%, marking a year-over-year decrease of 2351200.0%. This contributed to the annual value of 1431.66% for FY2024, which is 11273900.0% down from last year.
  • Latest data reveals that Caribou Biosciences reported FCF Margin of 1151.73% as of Q3 2025, which was up 4952100.0% from 1075.85% recorded in Q2 2025.
  • Caribou Biosciences' FCF Margin's 5-year high stood at 1274.78% during Q1 2021, with a 5-year trough of 1732.69% in Q4 2024.
  • Its 5-year average for FCF Margin is 840.62%, with a median of 855.8% in 2023.
  • Over the last 5 years, Caribou Biosciences' FCF Margin had its largest YoY gain of 5905700bps in 2022, and its largest YoY loss of -21251500bps in 2022.
  • Caribou Biosciences' FCF Margin (Quarter) stood at 862.6% in 2021, then rose by 16bps to 725.92% in 2022, then rose by 8bps to 664.87% in 2023, then crashed by -161bps to 1732.69% in 2024, then skyrocketed by 34bps to 1151.73% in 2025.
  • Its FCF Margin stands at 1151.73% for Q3 2025, versus 1075.85% for Q2 2025 and 1605.06% for Q1 2025.